Latest Ascelia Pharma News & Updates

See the latest news and media coverage for Ascelia Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Ascelia Pharma

Biotech company focused on orphan oncology drugs

ascelia.com

Headquarters: Malmö, Sweden
Founded year: 2000
Company type: Public company
Number of employees: 10–50
Industry: Pharmaceuticals

Last updated Today

Latest news about Ascelia Pharma

In short: Ascelia Pharma implemented cost-cutting measures and organizational changes after the FDA rejected its Orviglance drug application.

Company announcements

July 15 Ascelia Pharma

Ascelia Pharma announces organizational changes and reduced cost base

CFO Anton Hansson leaves the company, focus on FDA meeting for Orviglance.

July 3 Ascelia Pharma

Ascelia Pharma receives FDA Complete Response Letter for Orviglance NDA

The FDA requests additional clinical data and product documentation. Ascelia will seek a Type A meeting to find an expedited path forward.

June 30 Ascelia Pharma

Ascelia Pharma submits new patent application for Orviglance

The patent application covers innovations for packaging and manufacturing, which improves user-friendliness for patients and healthcare professionals.

May 11 Ascelia Pharma

Ascelia Pharma approaches FDA decision for Orviglance

The company reports reduced loss and strengthens cash ahead of partnership discussions. Orviglance's NDA is reviewed with decision on July 3, 2026.

Media coverage

July 22 Dagens PS

The stocks with the biggest price drops this year

Intrum leads with a price drop of over 90 percent during the first half of the year.

July 15 Morningstar

Ascelia Pharma Announces Organizational Changes and a Reduced Cost Base

MALMÖ, SE / ACCESS Newswire / July 15, 2026 / Ascelia Pharma (STO:ACE), a biotech company focused on improving the lives of people with rare...

July 13 The Globe and Mail

Ascelia Pharma Defends Orviglance Data After FDA Complete Response Letter

TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the...

July 6 Yahoo Finance

Ascelia Pharma AB N (7ZA.F) Q1 FY2026 earnings call transcript

Earnings call Ascelia Pharma reported a Q1 2026 operating loss of SEK 17 million, with costs down versus Q1 2025 due to the completion of...

Never miss news about Ascelia Pharma

Track Ascelia Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Ascelia Pharma competitors & trending companies

Browse news for competitors to Ascelia Pharma and other trending companies.